Search

everythinglearnresearchcommunity

for

Search:↓

Vervet monkeys show physical changes like hair loss and scrotal color changes due to stress or nutrition issues.

AGA can occur in children with family history; early diagnosis and treatment important.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Skin problems are very common in people with end-stage kidney disease.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.